Delivery Order SPE2DB24D1021-SPE2DB24FEUAC

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,313.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELECOXIB 200 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through March 10, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,563,043,087 units of the medication Celecoxib 200 mg Capsule, with a total ceiling value of $1,103.10. The contract is a firm fixed-price delivery order with a period of performance through December 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,441.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,174,033 units of the medication Celecoxib 200 mg capsule, with a completion date of May 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FDW89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,177,414 units of the drug Celecoxib 200 mg capsules, with a completion date of October 23, 2024 and a ceiling value of $2,886.07. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,298.08 firm fixed-price delivery order is for the supply of 4,565,092,057 Celecoxib 200 mg capsules. The contract has a period of performance through July 10, 2024 and does not include a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D3104|SPE2DB25FV4Q0, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.24 firm fixed-price delivery order is for the supply of 4,566,914,861 Celecoxib 200 mg capsules, a medication used for pain management and anti-inflammatory purposes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of CELECOXIB 200 MG CAPSULE 500S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,016.10 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on November 30, 2021. The contract has an ultimate completion date of December 1, 2021 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $4,969.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELEBREX 100 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 21, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $89,581.03 Firm Fixed Price delivery order is for Celebrex 200mg, a prescription medication used to treat arthritis and other pain conditions. The contract has an ultimate completion date of August 5, 2016 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUAC
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Celecoxib 200 mg capsules. The contract has a ceiling value of $20,786.08 and a completion date of September 11, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this prescription medication to support military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. The company has been awarded numerous contracts by the DLA and other federal agencies to supply a wide range of essential pharmaceutical and medical products, including specialty medications, generic drugs, and medical supplies. These contract vehicles enable government agencies to efficiently procure critical healthcare commodities for their beneficiaries.

Generated 12/10/24, 2:28 PM